Rigrodsky & Long, P.A. Announces Investigation Of MAP Pharmaceuticals, Inc. Buyout
January 24 2013 - 7:30AM
Business Wire
Rigrodsky & Long, P.A. announces that it is investigating
potential legal claims against the board of directors of MAP
Pharmaceuticals, Inc. (“MAP” or the “Company”) (NASDAQ GS: MAPP)
regarding possible breaches of fiduciary duties and other
violations of law related to the Company’s entry into an agreement
to be acquired by Allergan, Inc. (“Allergan”) (NYSE: AGN) in a
transaction valued at approximately $958 million, on a
fully-diluted basis.
Click here to learn more:
http://www.rigrodskylong.com/investigations/map-pharmaceuticals-inc-mapp.
Under the terms of the proposal, public shareholders of MAP will
receive $25.00 per share in cash for each share of MAP they
own.
The investigation concerns whether MAP’s board of directors
failed to adequately shop the Company and obtain the best possible
value for MAP’s shareholders before entering into an agreement with
Allergan.
If you own the common stock of MAP and purchased your shares
before January 22, 2013, if you have information or would like to
learn more about these claims, or if you wish to discuss these
matters or have any questions concerning this announcement or your
rights or interests with respect to these matters, please contact
Peter Allocco at Rigrodsky & Long, P.A., 825 East Gate
Boulevard, Suite 300, Garden City, New York 11530 toll free at
(888) 969-4242, by e-mail to info@rigrodskylong.com, or at:
http://www.rigrodskylong.com/investigations/map-pharmaceuticals-inc-mapp.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware
and Garden City, New York, regularly prosecutes securities class,
derivative and direct actions, shareholder rights litigation and
corporate governance litigation, on behalf of shareholders in
states and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a similar
outcome.
Map Pharmaceuticals, Inc. (MM) (NASDAQ:MAPP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Map Pharmaceuticals, Inc. (MM) (NASDAQ:MAPP)
Historical Stock Chart
From Jul 2023 to Jul 2024